Table 2.
Crude Event Rates in the 3, 6 and 12‐Month Landmark Cohorts, in Patients Receiving Drug‐Eluting Stents
Death | Death or MI | Death, MI or Repeat Revascularization | Major Bleeding Episode | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
N Events | Total p‐y | Events/100 p‐y | N Events | Total p‐y | Events/100 p‐y | N Events | Total p‐y | Events/100 p‐y | N Events | Total p‐y | Events/100 p‐y | |
3 M full cohort | ||||||||||||
Discontinued | 345 | 965 | 35.8 | 384 | 792 | 48.5 | 406 | 733 | 55.4 | 82 | 839 | 9.8 |
Continued | 1861 | 6417 | 29.0 | 2148 | 5242 | 41.0 | 2354 | 4718 | 49.9 | 484 | 5632 | 8.6 |
3 M matched cohort | ||||||||||||
Discontinued | 340 | 957 | 35.5 | 379 | 785 | 48.3 | 401 | 728 | 55.0 | 82 | 831 | 9.9 |
Continued | 316 | 978 | 32.3 | 361 | 796 | 45.4 | 388 | 710 | 54.6 | 83 | 864 | 9.6 |
6 M full cohort | ||||||||||||
Discontinued | 527 | 1615 | 32.6 | 603 | 1329 | 45.4 | 643 | 1229 | 52.3 | 125 | 1408 | 8.9 |
Continued | 1175 | 4175 | 28.1 | 1353 | 3510 | 38.5 | 1506 | 3166 | 47.6 | 295 | 3725 | 7.9 |
6 M matched cohort | ||||||||||||
Discontinued | 503 | 1577 | 31.9 | 579 | 1298 | 44.6 | 619 | 1198 | 51.7 | 119 | 1375 | 8.7 |
Continued | 500 | 1621 | 30.8 | 568 | 1358 | 41.8 | 621 | 1218 | 51.0 | 127 | 1428 | 8.9 |
12 M full cohort | ||||||||||||
Discontinued | 514 | 1513 | 34.0 | 577 | 1270 | 45.4 | 620 | 1191 | 52.1 | 114 | 1335 | 8.5 |
Continued | 514 | 1942 | 26.5 | 592 | 1697 | 34.9 | 667 | 1568 | 42.5 | 114 | 1762 | 6.5 |
12 M matched cohort | ||||||||||||
Discontinued | 405 | 1262 | 32.1 | 457 | 1068 | 42.8 | 496 | 1001 | 49.6 | 87 | 1120 | 7.8 |
Continued | 384 | 1290 | 29.8 | 426 | 1129 | 37.7 | 476 | 1046 | 45.5 | 81 | 1164 | 7.0 |
M indicates month; MI, myocardial infarction; p‐y, person‐years.